In-vivo quantification of hepatic 11β-hydroxysteroid dehydrogenase type I activity - A preliminary study

Clinical Biochemistry

Volumn 35, Issue 8, 2002, Pages 655-657

  Vogeser, Michael ^a   Gülberg, Veit ^a   Waggershauser, Tobias ^a   Gerbes, Alexander L ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; LIVER ENZYME;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CASE REPORT; DISEASE COURSE; ENDOSCOPIC SURGERY; ENDOSCOPIC THERAPY; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROPHYLAXIS; STOMACH HEMORRHAGE; STOMACH VARICES;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADULT; CORTISONE; FEMALE; HUMANS; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASES; LIVER; MALE; MIDDLE AGED;

EID: 0036868031     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(02)00379-X     Document Type: Article

References (20)

1. Krozowski Z., Li K.X., Koyama K., et al. The type I and type II 11beta-hyroxysteroid dehydrogenase enzymes. J Steroid Biochem Mol Biol. 69:1999;391-401.
2. Edwards C.R., Stewart P.M., Burt D., et al. Localisation of 11β-hydroxysteroid dehydrogenase -tissue specific protector of the mineralocorticoid receptor. Lancet. 2:(8618):1988;986-989.
3. Edwards C.R., Benediktsson R., Lindsay R.S., Seckl J.R. 11beta-Hydroxysteroid dehydrogenases key enzymes in determining tissue-specific glucocorticoid effects . Steroids. 61:1996;263-269.
4. Oppermann U.C., Persson B., Jornvall H. Function, gene organization and protein structures of 11beta-hydroxysteroid dehydrogenase isoforms. Eur J Biochem. 249:1997;355-360.
5. Jamieson P.M., Chapman K.E., Edwards C.R.W., Seckl J.R. 11β-Hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultured rat hepatocytes effect of physicochemical and hormonal manipulations . Endocrinology. 136:1995;4754-4761.
6. Voice M.W., Seckl J.R., Edwards C.R.W., Chapman K.E. 11β-hydroxysteroid dehydrogenasetype I expression in 2S FAZA hepatoma cells is hormonally regulated a model system for the study of hepatic glucocorticoid metabolism . Biochem J. 317:1996;621-625.
7. Ricketts M.L., Shoesmith K.J., Hewison M., Strain A., Eggo M.C., Stewart P.M. Regulation of 11β-hydroxysteroid dehydrogenase type 1 in primary cultures of rat and human hepatocytes. J Endocrinol. 156:1998;159-168.
8. Ricketts M.L., Verhaeg J.M., Bujalska I., Howie A.J., Rainey W.E., Stewart P.M. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 83:1998;1325-1335.
9. Seckl J.R., Walker B.R. 11β-hydroxysteroid dehydrogenase type 1 - A tissue-specific amplifier of glucocorticoid action. Endocrinology. 142:2001;1371-1376.
10. Rössle M., Ochs A., Gülberg V., et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 342:2000;1701-1707.
11. Vogeser M., Briegel J., Jacob K. Determination of serum cortisol by isotope-dilution liquid-chromatography electrospray ionization tandem mass spectrometry with on-line extraction. Clin Chem Lab Med. 39:2001;944-947.
12. Vogeser M., Zachoval R., Jacob K. Serum cortisol/cortisone ratio after Synacthen stimulation. Clin Biochem. 34:2001;421-425.
13. Escher G., Nawrocki A., Staub T., Vishwanath B.S., Frey B.M., Reichen J., Frey F.J. Down-regulation of hepatic and renal 11 beta-hydroxysteroid dehydrogenase in rats with liver cirrhosis. Gastroenterology. 114:1998;175-184.
14. Richter G.M., Palmaz J.C., Noldge G., Rossle M., Siegerstetter V., Franke M., Wenz W. The transjugular intrahepatic portosystemic stent-shunt. A new nonsurgical percutaneous method. Radiologe. 29:1989;406-411.
15. Gerbes A.L., Gülberg V., Waggershauser T., Holl J., Reiser M. Renal effects of transjugular intrahepatic portosystemic shunt (Trends Pharmacol Sci) in cirrhosis of the liver comparison of patients with ascites, with refractory ascites, or without ascites . Hepatology. 28:1998;683-688.
16. Rössle M., Siegerstetter V., Huber M., Ochs A. The first decade of the transjugular intrahepatic portosystemic shunt (Trends Pharmacol Sci) state of the art . Liver. 18:1998;73-89.
17. Hellman L., Nakada F., Zumoff B., Fukushima D., Bradlow H.L., Gallagher T.F. Renal capture and oxidation of cortisol in man. J Clin Endocrinol Metab. 33:1971;52-62.
18. Whitworth J.A., Stewart P.M., Burt D., Atherden S.M., Edwards C.R. The kidney is the major site of cortisone production in man. Clin Endocrinol. 31:1989;355-361.
19. Bolognesi M., Sacerdoti D., Bombonato G., et al. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology. 35:2002;601-608.
20. Vogeser M, Zachoval R, Felbinger TW, Jacob K. Increased ratio of serum cortisol to cortisone in acute phase response. Horm Res 2002 (in press).